| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/13/2010 | US20100122374 Disease resistance in plants by introducing transcription factor gene |
| 05/13/2010 | US20100122365 Optimizing glycan processing in plants |
| 05/13/2010 | US20100122358 H-Chain-only antibodies |
| 05/13/2010 | US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 05/13/2010 | US20100121035 Purification of immunoglobulins |
| 05/13/2010 | US20100121033 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 05/13/2010 | US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120124 Systems, methods and microrganisms for antibody production with type iii secretion system |
| 05/13/2010 | US20100120064 Antibody specific to intact human autotaxin, method of screening the same and method and reagent for examining malignant lymphoma by assaying autotaxin |
| 05/13/2010 | US20100120056 Diagnosis and monitoring of diseases |
| 05/13/2010 | US20100120055 Tyrosine phosphorylation sites |
| 05/13/2010 | US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/13/2010 | US20100119536 Naturally Processed Measles Virus Peptides From Class II HLA Molecules |
| 05/13/2010 | US20100119533 Polynucleotides and Polypeptides Identified by IVIAT Screening and Methods of Use |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119526 DLL4 Signaling Inhibitors and Uses Thereof |
| 05/13/2010 | US20100119524 Adjuvanted vaccine |
| 05/13/2010 | US20100119523 Vascular endothelial cell growth factor antagonists |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119520 Monoclonal antibodies that neutralize anthrax toxins |
| 05/13/2010 | US20100119518 Target for breast cancer therapy and/or diagnosis |
| 05/13/2010 | US20100119516 Anti-tgf-beta receptor ii antibodies |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119514 Antibodies Against Cancer |
| 05/13/2010 | US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 05/13/2010 | US20100119511 Light targeting molecules and uses thereof |
| 05/13/2010 | US20100119509 Polynucleotides and polypeptides associated with the development of rheumatoid arthritis |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119506 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation |
| 05/13/2010 | US20100119505 Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119445 Plexin d1 as a target for tumor diagnosis and therapy |
| 05/12/2010 | EP2184355A1 Antibody modified with hydrophobic molecule |
| 05/12/2010 | EP2184298A1 Antibodies against human IL-21 receptor and uses therefor |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2184085A1 Treatment of diseases |
| 05/12/2010 | EP2184067A1 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/12/2010 | EP2183599A1 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest |
| 05/12/2010 | EP2183596A1 Method and means for prediction of systemic lupus erythematosus susceptibility |
| 05/12/2010 | EP2183366A1 Immunogenic polypeptides and monoclonal antibodies |
| 05/12/2010 | EP2183282A1 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
| 05/12/2010 | EP2183281A1 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
| 05/12/2010 | EP2183007A1 Needle-free delivery device for therapeutic proteins based on single antigen-binding domains such as nanobodies® |
| 05/12/2010 | EP2182983A1 Treatment of amyloidogenic diseases |
| 05/12/2010 | EP2182982A2 Therapeutic use of anti-tweak receptor antibodies |
| 05/12/2010 | EP2182981A2 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 05/12/2010 | EP1578772B1 Cytokines and cytokine receptors with reduced immunogenicity |
| 05/12/2010 | EP1578374B1 Escape mutants of newcastle disease virus as marker vaccines |
| 05/12/2010 | CN1974600B Flumequine resisting monoclonal antibody and its preparation process and application |
| 05/12/2010 | CN1948335B Candida albicans mycellium regulating and controlling factor gene and its use |
| 05/12/2010 | CN1933853B Drug conjugates |
| 05/12/2010 | CN1908006B Method of fast purifying and preparing Fab fragment antibody |
| 05/12/2010 | CN1844151B Monoclonal antibody against human CD40 mutant molecule and its use |
| 05/12/2010 | CN1738643B Composition and method for preventing or treating a virus infection |
| 05/12/2010 | CN1657618B Hepatic correlative oncogene inhibitory and use |
| 05/12/2010 | CN1630663B Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 05/12/2010 | CN1612895B Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/12/2010 | CN1599750B Cytotoxic protein and utilization thereof |
| 05/12/2010 | CN1486365B Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 05/12/2010 | CN1426423B Humanized antibodies that sequester amyloid beta peptide |
| 05/12/2010 | CN101707882A Pdgfrss-specific inhibitors |
| 05/12/2010 | CN101706507A Application of anti-human CD45RA monoclonal antibody marked by fluorescein isothiocyanate |
| 05/12/2010 | CN101705233A Recombinant human herpes simplex virus I protein HSV I gG and application thereof |
| 05/12/2010 | CN101705231A Apis cerana royal jelly antibacterial peptide AccRoyalisin gene and encoded polypeptide thereof and application thereof |
| 05/12/2010 | CN101705210A Anti-melamine monoclonal antibody and application thereof |
| 05/12/2010 | CN101704892A Anti-uPAR humanized antibody, coding gene and application thereof |
| 05/12/2010 | CN101704891A Antibody for epidermal growth factor receptor, encoding gene thereof and application thereof |
| 05/12/2010 | CN101704890A Preparation method of duck hepatitis antibody |
| 05/12/2010 | CN101704889A Method for preparing chicken bursal antibody |
| 05/12/2010 | CN101704879A Novel immunoglobulin-binding proteins with improved specificity |
| 05/12/2010 | CN101058604B FK gene, coding protein and application thereof |
| 05/11/2010 | USRE41328 Purification of Heparinase I, II and III from Flavobacterium heparinum |
| 05/11/2010 | US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein |
| 05/11/2010 | US7714120 Humanized anti-IL-1 beta antibodies |
| 05/11/2010 | US7714113 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 05/11/2010 | US7714112 a mobile phase comprising sample is contacted with a multi-modal separation matrix to adsorb undesired compounds while the antibodies remain free in the liquid; requires less time and process steps than the prior art methods |
| 05/11/2010 | US7714111 Antibodies specific for myostatins; reduced turbidity, impurities |
| 05/11/2010 | US7714110 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 05/11/2010 | US7714109 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 05/11/2010 | US7714108 Mammalian tumor susceptibility gene products and their uses |
| 05/11/2010 | US7714105 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 05/11/2010 | US7713737 delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker |
| 05/11/2010 | US7713712 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid |
| 05/11/2010 | US7713699 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 05/11/2010 | US7713528 Method for in vivo delivery of active compounds using reagent conjugate |
| 05/11/2010 | US7713526 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/11/2010 | US7713524 treating hemolytic disease of the newborn, Sezary Syndrome, chronic myeloid leukemias, chronic lymphoid leukemias (CLL-B), cancer, breast cancer, conditions related to the environment, infectious diseases, chronic fatigue syndrome (CFS), parasitic infections, or viral infections |
| 05/11/2010 | CA2527225C Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 05/11/2010 | CA2434512C Marker for inflammatory conditions |
| 05/11/2010 | CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 05/11/2010 | CA2279517C Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 05/11/2010 | CA2184493C Methods and compositions useful for inhibition of angiogenesis |
| 05/11/2010 | CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins |
| 05/11/2010 | CA2165297C Myeloid cell leukemia associated gene mcl-1 |
| 05/08/2010 | CA2738644A1 Hepatitis c antibodies and uses thereof |
| 05/06/2010 | WO2010051502A2 Light targeting molecules and uses thereof |
| 05/06/2010 | WO2010051391A1 Use of anti-cs1 antibodies for treatment of rare lymphomas |
| 05/06/2010 | WO2010051360A1 Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| 05/06/2010 | WO2010051347A1 A method for cardioprotection |